FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services home page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

FY04 OCP Review Performance:

Formal Requests for Designation Submitted by Industry

October 1, 2003 – September 30, 2004

 

 

Combination
Products


Non-Combination
Products

Total

Pending Beginning of Period

1

2

3

Original RFDs Submitted*

32

23

55

Requests for Reconsideration Submitted

1

2

3

Total

34

27

61

Original RFD Decisions Issued

26

15

41

Responses to Requests for Reconsideration Issued

1

1

2

RFD’s Withdrawn During Period

3

2

5

Pending at End of Period:

Not overdue

Overdue

Reconsiderations



4

0

0



8

0

1



12

0

1

Total

34

27

61

Assignments

CBER






CDER







CDRH



3 total:

2 device/biologic
1 drug/device/biologic



6 total:

5 drug/device
1 device/biologic



17 total:

15 drug/device
  2 device/biologic



2 total:

1 device
1 biologic


4 total:

4 drug
 [3 original;
  1 reconsideration]


11 total:

          11 device
         [10 original;
           1 reconsideration]



5





10






28

Total

26

17

43

Mean Total Review Time§

38.3 days

44.8 days

40.7

Median Total Review Time§

35 days

45 days

41.0

Range of Total Review Time§

18-59 days

31-59 days

18-59

* Nine original RFDs received were not filed due to insufficient information.
One original decision changed from combination product to non-combination product assigned to CDRH
One original decision confirmed
§
Based on 41 original RFD decisions. Two requests for reconsideration responded to within 15 day timeframe required by 21 CFR 3.8(c)

horizontal rule